Actively Recruiting

All Genders
ID06211218

Application of Deep Learning for Screening Multiple Corneal Diseases

Led by Tianjin Eye Hospital · Updated on 2024-11-04

3000

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating a deep learning algorithm designed to identify multiple corneal diseases using anterior segment images. The study aims to validate this algorithm by measuring its accuracy through sensitivity, specificity, positive predictive value, negative predictive value, and area under the curve. The study is observational and focuses on improving screening methods for corneal diseases. The intervention involves applying the artificial intelligence algorithm to diagnose corneal diseases from slit-lamp images. The algorithm analyzes key regions in the images, including the sclera, pupil, and lens, to detect disease presence. There are no treatment groups since this is a diagnostic study. Participants provide slit-lamp images that must meet quality standards, ensuring over 90% of the image area is clear for reading and discrimination. Researchers assess the algorithm's performance by comparing its diagnoses with clinical standards within one week. Outcome measures include the area under the curve, sensitivity, and specificity. The study is conducted under the oversight of Tianjin Eye Hospital and does not involve healthy volunteers.

CONDITIONS

Brief Title

Artificial Intelligence for Screening of Multiple Corneal Diseases

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • The quality of slit-lamp images should be clinically acceptable
  • More than 90% of the slit-lamp image area including sclera, pupil, and lens must be clear and easy to read for diagnosis
Not Eligible

You will not qualify if you...

  • Insufficient information available for diagnosis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Diagnostic Evaluation

Duration - 1 week

Participants undergo slit-lamp imaging which is analyzed by an artificial intelligence algorithm to diagnose cornea diseases.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Tiajin Eye Hospital

Tianjin, Tianjin Municipality, China

Actively Recruiting

Loading map...

Research Team

Y

Yan Huo, Master

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Safety and Clinical Activity Study of Belantamab Mafodotin W...

Multiple Myeloma

Actively Recruiting

2 locations

AI Facial Analysis Algorithm to Screening Coronary Artery Di...

Coronary Artery Disease (CAD)

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here